logo-loader

Redx Pharma initiates search for new chair as Iain Ross steps down

Published: 08:01 01 Jun 2021 BST

Redx Pharma PLC -

Redx Pharma PLC (LON:REDX), the drug discovery and development company focused on cancer and fibrosis, said non-executive chairman Iain Ross is stepping down from his role as a director.

Peter Presland, currently a non-executive director of Redx, has been appointed as interim chairman with immediate effect.

A search is underway for a permanent replacement.

"Iain has been the lynchpin in the turnaround of Redx and we are very grateful for his innumerable contributions as chairman over the last four years,” said Lisa Anso, the chief executive of Redx.

Redx Pharma achieves milestone with dosing of first participant in Phase 1...

  Redx Pharma PLC (AIM:REDX) CEO Lisa Anson discusses the enrollment of the first participant in its RXC008 Phase 1 clinical trial in an interview with Proactive's Stephen Gunnion. RXC008 is a 'first-in-class' ROCK inhibitor, designed to be gut-restricted, targeting fibrostenotic Crohn's...

1 month ago